-
Product Insights
NewT Cell Specific Surface Glycoprotein CD28 – Drugs In Development, 2024
The T Cell Specific Surface Glycoprotein CD28 pipeline drugs market research report outlays comprehensive information on the T Cell Specific Surface Glycoprotein CD28 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Ophthalmology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Kidney Transplant Rejection, Graft Versus Host Disease (GVHD), Uveitis,...
-
Product Insights
NewVoltage Dependent T Type Calcium Channel Subunit Alpha 1G – Drugs In Development, 2024
The Voltage Dependent T Type Calcium Channel Subunit Alpha 1G pipeline drugs market research report outlays comprehensive information on the Voltage Dependent T Type Calcium Channel Subunit Alpha 1G targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Dermatology, and Cardiovascular which include indications of Alzheimer's Disease, Neuropathic Pain (Neuralgia), Oncology, Pruritus, and Cardiovascular...
-
Product Insights
NewVoltage Dependent T Type Calcium Channel Subunit Alpha 1H – Drugs In Development, 2024
The Voltage Dependent T Type Calcium Channel Subunit Alpha 1H pipeline drugs market research report outlays comprehensive information on the Voltage Dependent T Type Calcium Channel Subunit Alpha 1H targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Dermatology, and Toxicology which include indications of Neuropathic Pain (Neuralgia), Pain, Pruritus, and Chemotherapy Induced Peripheral Neuropathy....
-
Product Insights
NewOxford Immunotec Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Oxford Immunotec Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have...
-
Sector Analysis
NewMobility Market Size, Trends, Drivers and Challenges, Vendor Landscape, Opportunities and Forecast to 2027
Mobility Market Report Overview The global mobility market size was pegged at more than $36 billion in 2022. The market is expected to grow at a CAGR of more than 15% during the forecast period (2022-2027). The significant rise in the adoption of mobile solutions in enterprises has led to a parallel rise in demand for enterprise mobility management (EMM) solutions, which enable IT administrators to simplify and secure enterprise mobility implementations in their organizations. Mobility Market Outlook, 2022-2027 ($...
-
Product Insights
NewSorrento Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Sorrento Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sorrento Therapeutics Inc (Sorrento) is a biopharmaceutical company that focuses on developing therapeutics for the treatment of cancer, osteoarthritis and autoimmune diseases. The company’s immunotherapy pipeline portfolio consists of a CD38 CAR-T, CD38 ADC, CD38 DAR-T and Sephrehvir for the treatment of cancer. Sorrento is also investigating COVID19 programs which include Coviguard, Covidrops and Covishield, among others for the...
-
Product Insights
NewImaginAb Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ImaginAb Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ImaginAb Inc (ImaginAb) is a biotechnology company that develops imaging solutions for immuno-oncology diseases. It is investigating PET imaging solutions for imaging of CD8 cells in oncology, CD8 T-cells in inclusion body myositis and CD4 T-cells trafficking in oncology and autoimmune diseases; and optical imaging solutions for prostate and renal cancer. The company is also evaluating radiopharmaceutical therapies including IAB2MA...
-
Sector Analysis
NewBusiness of the Golf Majors 2024 – Property Profile, Sponsorship and Media Landscape
Golf Majors 2024 Report Overview Golf is one of the most popular sports in the world and is enjoyed equally at both professional and personal levels. Many amateurs play regularly throughout the year making the sports popular at a recreational level. At a professional level, golf involves a huge amount of money. This, in turn, has made the elite players some of the most well-paid global athletes. The PGA Championship has the largest sponsorship inventory of ‘The Majors’ while ‘The...
-
Product Insights
NewAdaptive Biotechnologies Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Adaptive Biotechnologies Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Adaptive Biotechnologies Corp (Adaptive) is a developer of immune-driven medicine. Its products include immunoSEQ, T-Detect, Vaccines and clonoSEQ. The company provides immune-sequencing platform to laboratories for conducting research in the areas of oncology and other immune-mediated diseases, and TCR screening for the development of vaccines. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of...
-
Product Insights
NewCareDx Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our CareDx Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. CareDx Inc (CareDx) is a diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. Its products include AlloSure, AlloMap, AlloSeq T 17, AlloSeq T 8, Qtype, Olerup SSP and SBT, Trusight, AlloSeq cfDNA, HeartCare, KidneyCare, Ottr Organ, Ottr Cellular, XynQAPI, TxAccess, XynCare, AlloCare, AlloCell and AlloSeq HCT. The company provides laboratory products along the...